dc.contributor.authors |
Ayas, ZO; Kotan, D; Akdogan, M; Gunel, ME; |
|
dc.date.accessioned |
2020-02-27T08:29:16Z |
|
dc.date.available |
2020-02-27T08:29:16Z |
|
dc.date.issued |
2019 |
|
dc.identifier.citation |
Ayas, ZO; Kotan, D; Akdogan, M; Gunel, ME; (2019). Serum Prolidase Enzyme Activity Level: Not a Predictive Biomarker for Epilepsy. EURASIAN JOURNAL OF MEDICINE, 51, 30-27 |
|
dc.identifier.issn |
1308-8734 |
|
dc.identifier.uri |
https://doi.org/10.5152/eurasianjmed.2018.18183 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12619/66127 |
|
dc.description.abstract |
Conclusion: Our study results suggest that although PEA is an enzyme associated with OS and inflammation, it is still not an ideal biomarker for epileptic patients. This study is important because it investigated PEA in patients with idiopathic epilepsy for the first time. |
|
dc.language |
English |
|
dc.publisher |
AVES |
|
dc.rights |
info:eu-repo/semantics/openAccess |
|
dc.rights.uri |
http://creativecommons.org/licenses/by/4.0/ |
|
dc.subject |
General & Internal Medicine |
|
dc.title |
Serum Prolidase Enzyme Activity Level: Not a Predictive Biomarker for Epilepsy |
|
dc.type |
Article |
|
dc.identifier.volume |
51 |
|
dc.identifier.startpage |
27 |
|
dc.identifier.endpage |
30 |
|
dc.contributor.department |
Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü |
|
dc.contributor.saüauthor |
Kotan Dündar, Dilcan |
|
dc.contributor.saüauthor |
Akdoğan, Mehmet |
|
dc.contributor.saüauthor |
Günel, Mustafa Ercan |
|
dc.relation.journal |
EURASIAN JOURNAL OF MEDICINE |
|
dc.identifier.wos |
WOS:000462160900007 |
|
dc.identifier.doi |
10.5152/eurasianjmed.2018.18183 |
|
dc.identifier.eissn |
1308-8742 |
|
dc.contributor.author |
Zeynep Ozozen Ayas |
|
dc.contributor.author |
Kotan Dündar, Dilcan |
|
dc.contributor.author |
Akdoğan, Mehmet |
|
dc.contributor.author |
Günel, Mustafa Ercan |
|